Disease Drug Trials FDA Approval RNA 
Drug Discovery World
MARCH 7, 2023
Here at FAB our proprietary approach aims to overcome this fundamental challenge to human health as we work to discover and develop new drugs for age-associated diseases.” She founded Neuroute in 2019, with the aim of empowering patients from diverse backgrounds to participate in drug trials.
Drug Discovery World
JANUARY 17, 2024
Liquid biopsies have specific advantages over the current gold standard for tumour characterisation, tissue biopsies: not only are they less invasive and less costly, they provide results faster, are more suitable for longitudinal disease monitoring and less likely to cause harmful side effects.
Expert insights. Personalized for you.
246 
Let's personalize your content